全文获取类型
收费全文 | 124552篇 |
免费 | 10302篇 |
国内免费 | 6727篇 |
专业分类
耳鼻咽喉 | 1017篇 |
儿科学 | 2705篇 |
妇产科学 | 1375篇 |
基础医学 | 23659篇 |
口腔科学 | 2242篇 |
临床医学 | 9339篇 |
内科学 | 18390篇 |
皮肤病学 | 2141篇 |
神经病学 | 8317篇 |
特种医学 | 2503篇 |
外国民族医学 | 47篇 |
外科学 | 11367篇 |
综合类 | 20344篇 |
现状与发展 | 29篇 |
一般理论 | 1篇 |
预防医学 | 5686篇 |
眼科学 | 1791篇 |
药学 | 14113篇 |
11篇 | |
中国医学 | 3748篇 |
肿瘤学 | 12756篇 |
出版年
2024年 | 341篇 |
2023年 | 1956篇 |
2022年 | 4050篇 |
2021年 | 4721篇 |
2020年 | 3887篇 |
2019年 | 4081篇 |
2018年 | 4087篇 |
2017年 | 4188篇 |
2016年 | 4157篇 |
2015年 | 4593篇 |
2014年 | 6821篇 |
2013年 | 8408篇 |
2012年 | 6973篇 |
2011年 | 8400篇 |
2010年 | 6773篇 |
2009年 | 6790篇 |
2008年 | 6761篇 |
2007年 | 6793篇 |
2006年 | 6352篇 |
2005年 | 5698篇 |
2004年 | 5197篇 |
2003年 | 4465篇 |
2002年 | 3651篇 |
2001年 | 3193篇 |
2000年 | 2793篇 |
1999年 | 2325篇 |
1998年 | 2096篇 |
1997年 | 1835篇 |
1996年 | 1388篇 |
1995年 | 1315篇 |
1994年 | 1040篇 |
1993年 | 796篇 |
1992年 | 636篇 |
1991年 | 556篇 |
1990年 | 476篇 |
1989年 | 385篇 |
1988年 | 299篇 |
1987年 | 272篇 |
1986年 | 251篇 |
1985年 | 442篇 |
1984年 | 464篇 |
1983年 | 273篇 |
1982年 | 330篇 |
1981年 | 265篇 |
1980年 | 221篇 |
1979年 | 178篇 |
1978年 | 127篇 |
1977年 | 120篇 |
1976年 | 133篇 |
1975年 | 89篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
Population-based association studies are powerful tools for the genetic mapping of complex diseases. However, this method is sensitive to potential confounding by population structure. While statistical methods that use genetic markers to detect and control for population structure have been the focus of current literature, the utility of self-defined race/ethnicity in controlling for population structure has been controversial. In this study of 1334 individuals, who self-identified as either African American, European American or Hispanic, we demonstrated that when the true underlying genetic structure and the self-defined racial/ethnic groups were roughly in agreement with each other, the self-defined race/ethnicity information was useful in the control of population structure. 相似文献
32.
Regulation of erythropoietin production 总被引:6,自引:0,他引:6
33.
腰椎后路非融合固定系统的临床应用 总被引:11,自引:1,他引:10
复习腰椎后路非融合固定系统的设计原理、临床应用及治疗效果等相关文献,与传统的脊柱融合术相比,应用非融合系统可获得很好的疗效,并可以减少邻近节段退变的发生率。 相似文献
34.
高度近视的病因学研究进展 总被引:9,自引:0,他引:9
高度近视发生的内因、外因,包括遗传倾向,相关基因定位,巩膜胶原白体免疫学说,视网膜生物活性物质失调学说,环境因素等,本研究就这些因素对高度近视发病的影响做一综述。现统一的认识有:①高度近视具有明显的遗传倾向。②迄今为止,已找到4个高度近视相关基因,它们的遗传方式均为常染色体显性遗传。③高度近视的巩膜组织病理改变和胶原代谢障碍引发了人们对高度近视免疫相关基因的深入研究。已发现HLAⅡ类基因与部分高度近视具有相关性。④视网膜中存在的生物活性物质直接或间接参与了形觉剥夺性近视的形成。⑤环境因素并非高度近视发病的决定因素,它仅起一定程度的促进作用。将今后的工作重点放在高度近视基因定位的研究,基因表达的调控及巩膜胶原代谢、网膜生物活性物质之间的关系研究上,无疑会进一步揭示高度近视的病因,为防治高度近视开辟新途径。 相似文献
35.
Histopathological characterisation of effects of the mouse Pax6 missense mutation on eye development
Thaya Ramaesh Steven E. Williams Catriona Paul Kanna Ramaesh John D. West 《Experimental eye research》2009,89(2):263-273
Mutations in PAX6/Pax6 lead to a variety of ocular anomalies in humans and mice. The aim of the study was to characterise the ocular abnormalities caused by the missense Pax6Leca4 mutation and compare them to published observations on Pax6 alleles that are functionally equivalent to Pax6− null alleles (such as Pax6Sey and Pax6Sey-Neu) and human inherited eye diseases. Ocular features of homozygous Pax6Leca4/Leca4 and heterozygous Pax6Leca4/+ embryos at E12.5-E18.5, heterozygous Pax6Leca4/+ young mice at P18 and heterozygous Pax6Leca4/+ adults at 12 weeks were analysed histologically with their wild-type Pax6+/+ littermates. Homozygous Pax6Leca4/Leca4 fetuses died perinatally with no eyes although an optic cup rudiment with pigmented cells developed. Pax6Leca4/+ mice were microphthalmic and a range of other severe ocular phenotypes affected both the anterior and the posterior segments. In contrast to Pax6+/−, the Pax6Leca4/+ eyes had no goblet cells in the corneal epithelium, the iris was not hypoplastic and there was no lens-corneal epithelial plug. However, microphthalmia was more severe, corneal vascularisation occurred earlier (during fetal stages), pigmented cells were present in the vitreous and corneal stroma and the ciliary body was malformed or abnormal. These results show that, although Pax6Leca4/+ lacked some eye abnormalities commonly seen in Pax6Sey/+ and Pax6Sey-Neu/+ eyes, in most respects their eyes were more severely affected. These differences probably reflect both differences between the Pax6Leca4 and the Pax6Sey-Neu mutations and differences in modifier gene expression in different genetic backgrounds. The presence of pigmented cells in the cornea is a novel observation. Some Pax6Leca4/+ ocular abnormalities were similar to those present in human Peters' anomaly and persistent hyperplastic primary vitreous (PHPV) so Pax6Leca4/+ mice provide a useful model for some inherited eye diseases. 相似文献
36.
37.
Chandipura virus (CHPV) has emerged as an important pediatric encephalitis-causing pathogen with very high mortality in India. No specific vaccine or treatment is available till date. We attempted to prepare a candidate vaccine employing recombinant CHPV Glycoprotein (rGp). The Glycoprotein gene (G-gene) of CHPV was expressed using Baculovirus expression system. The rGp was purified by HPLC and used for mice immunization, 3 doses, and 4 weeks apart. One microgram rGp was found to be optimum. Sero-conversion was observed as early as 2nd week by detecting anti-CHPV IgG antibodies. Antibody titres were immunogen-concentration dependent. Intracerebral challenge of the immunized mice with 100 LD50 of the homologous strain demonstrated 90% protection. In in vitro neutralization, antibodies from the immunized mice were able to neutralize heterologous viruses. There was 60% T cell proliferation observed against rGp in immunized mice. The study shows that rGp induces both arms of immune response and represents an ideal vaccine candidate for further evaluations. 相似文献
38.
Robert M. Levy Roman Saikovsky Evgeniya Shmidt Alexander Khokhlov Bruce P. Burnett 《Nutrition Research》2009
Flavocoxid (Limbrel), a proprietary mixture of flavonoid molecules (baicalin and catechin), was tested against a traditional nonsteroidal anti-inflammatory drug, naproxen, for the management of the signs and symptoms of moderate osteoarthritis (OA) in humans. Discomfort and global disease activity were used as the primary end points, and safety assessments were also taken for both treatments as a secondary endpoint. In this double-blind study, 103 subjects were randomly assigned to receive either flavocoxid [500 mg twice daily (BID)] or naproxen (500 mg BID) in a 1-month onset of action trial. Outcome measures included the short Western Ontario and McMaster University Osteoarthritis Index, subject Visual Analogue Scale for discomfort and global response, and investigator Visual Analogue Scale for global response and fecal occult blood. Both flavocoxid and naproxen showed significant reduction in the signs and symptoms of knee OA (P ≤ .001). There were no statistically detectable differences between the flavocoxid and naproxen groups with respect to any of the outcome variables. Similarly, there were no statistically detectable differences between the groups with respect to any adverse event, although there was a trend toward a higher incidence of edema and nonspecific musculoskeletal discomfort in the naproxen group. In this short-term pilot study, flavocoxid was as effective as naproxen in controlling the signs and symptoms of OA of the knee and would present a safe and effective option for those individuals on traditional nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors. A low incidence of adverse events was reported for both groups. 相似文献
39.
瘢痕疙瘩是烧伤外科研究的重要课题,其形成机制尚未完全明确,本文就其在遗传机制、免疫作用、细胞增殖与胶原代谢、细胞因子等方面的研究进展进行综述。 相似文献
40.